HCG Manavata Cancer Centre is Maharashtra's first NABH-accredited cancer hospital with advanced PET-CT and radiotherapy units. Diagnostics start from around A$280 for fusion biopsy. Melanoma treatments include immune checkpoint inhibitor therapy with Keytruda, typically running A$4,500–6,600, plus targeted oral therapy for BRAF mutation cases. The centre is audited by the US-FDA and treats over 75,000 patients yearly. Dr Shaunak Valame focuses on molecular oncology and targeted therapies, backed by training at Tata Memorial and Apollo.